Hong Kong Biotech Stock News

China Resources Beer (Holdings) Company Limited ( HKG:291 ) stock is about to trade ex-dividend in three days. The...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Galaxy...

Infinity Development Holdings (SEHK:640) has put up a steady set of H1 2026 numbers, with revenue of HK$425.8 million, net income of HK$65.6 million and basic EPS of HK$0.23, backed by trailing 12 month revenue of HK$827.4 million and net income of HK$114.4 million. The company has seen revenue move from HK$403.8 million and EPS of HK$0.21 in H2 2024 to HK$409.3 million and EPS of HK$0.20 in H1 2025, then to HK$425.8 million and EPS of HK$0.23 in H2 2025. This sets up a picture where margins...

Fresh research from Bank of America Securities, Everbright Securities and Daiwa has put China Overseas Land & Investment (SEHK:688) back in focus, highlighting sector recovery signals and company specific sales and earnings expectations. See our latest analysis for China Overseas Land & Investment. At a share price of HK$16.51, the stock has seen a 31.87% 1 month share price return and a 32.19% year to date share price return, while the 1 year total shareholder return of 27.64% points to...

Recent share performance and business snapshot TCL Electronics Holdings (SEHK:1070) has drawn investor attention after a period where the stock is up about 14% over the past month and about 25% over the past 3 months. That share performance sits against a backdrop of HK$118,456.688m in revenue and HK$2,693.784m in net income, with both metrics showing annual growth, and a market value of about HK$39.7b. See our latest analysis for TCL Electronics Holdings. At the current share price of...

Fameglow Holdings (SEHK:8603) has released its FY 2026 first half results, reporting revenue of HK$284.6 million and basic EPS of HK$0.026, with trailing 12 month figures showing revenue of HK$550.4 million and EPS of HK$0.0627. Over the past reported periods, revenue has moved from HK$169.5 million in 1H FY 2025 to HK$265.8 million in 2H FY 2025 and HK$284.6 million in 1H FY 2026. Basic EPS has shifted from HK$0.0205 to HK$0.0366 and then HK$0.026, setting the scene for investors to weigh a...

InSilico Medicine Cayman TopCo (SEHK:3696) announced a new collaboration with Suzhou Ribo Life Science focused on AI-driven oligonucleotide drug development. The partnership combines InSilico's automation and AI platforms with Ribo's expertise in oligonucleotide therapies across the drug discovery and R&D pipeline. The companies aim to apply AI tools to target identification, molecule design, and preclinical work to support future oligonucleotide candidates. For investors tracking...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Perennial...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It's shaping up to be a tough period for Alibaba Health Information Technology Limited ( HKG:241 ), which a week ago...

Mixed recent returns and valuation snapshot New World Development (SEHK:17) has had a mixed return profile, with the stock up 0.4% over the past day and 1.6% over the past month, but down 6.3% over the past week and 16.0% over the past 3 months. Over longer periods, the stock is up 21.7% year to date and 90.1% over the past year, while the 3 year and 5 year total returns show declines of 46.0% and 69.8%, respectively. This highlights how timing has shaped outcomes for different holders. At a...

Man Wah Holdings (SEHK:1999) FY 2026 results in focus Man Wah Holdings (SEHK:1999) has put fresh numbers on the table for FY 2026, with first half revenue of HK$8.0b and basic EPS of HK$0.30 setting the tone against a current share price of HK$3.97. The company has seen half year revenue move from HK$8.3b in the first half of FY 2025 to HK$8.6b in the second half and then to HK$8.0b in the first half of FY 2026. Basic EPS has ranged between HK$0.24 and HK$0.30 over the same stretch, giving a...

Sunac China Holdings (SEHK:1918) fell 4.5% as investors reacted to ongoing pressure in China's real estate sector and the company's leverage and liquidity challenges, with attention now turning to its September 2, 2026, earnings release. See our latest analysis for Sunac China Holdings. At a latest share price of HK$1.04, Sunac China Holdings has seen pressure build over time, with the 7 day share price return down 10.34% and the 1 year total shareholder return down 25.71%. This suggests...

Recent share performance and company snapshot Zhejiang Leapmotor Technology (SEHK:9863) has drawn attention after a mixed stretch in the stock, with a small gain over the past day, offset by declines over the past week, month and past 3 months. For readers looking at the core business behind those moves, the company focuses on research, development, production and sales of new energy vehicles across multiple series and body types, with operations in Mainland China, Europe and other...

MiniMax Group stock: context for recent returns MiniMax Group (SEHK:100) has drawn attention after recent share price swings, with the stock down about 6% over the past month but up roughly 17% in the past 3 months. See our latest analysis for MiniMax Group. Stepping back, MiniMax Group’s recent share price return shows short term momentum fading after a sharp run, with the stock down over the past month but still strongly higher year to date, as investors reassess growth potential and risk...

Wise Living Technology Co., Ltd ( HKG:2481 ) is about to trade ex-dividend in the next three days. The ex-dividend date...

Sinopec, listed as SEHK:386, has received official approval for China's first ultra-deep shale gas field at Ziyang Dongfeng. The project is confirmed at the 100 billion cubic meter level of proven shale gas reserves. The company used its own AI-driven exploration technology and ultra-deep drilling techniques to support the discovery. China Petroleum & Chemical (SEHK:386), trading at HK$4.49, has a mixed share price record, with the stock down 4.5% year to date but up 18.2% over the past...

Tencent Holdings (SEHK:700) continues to draw investor attention after a period of weaker share performance, with the stock down 8.5% over the past month and 14.2% over the past 3 months. See our latest analysis for Tencent Holdings. At a share price of HK$456.4, Tencent’s recent loss of momentum, including the 26.7% decline in the year to date, contrasts with the stronger 3 year total shareholder return of 41.0%. This suggests sentiment has cooled even as long term holders remain ahead...

Last week saw the newest first-quarter earnings release from Yue Yuen Industrial (Holdings) Limited ( HKG:551 ), an...

China Everbright Limited ( HKG:165 ) is about to trade ex-dividend in the next four days. The ex-dividend date is...

Last week, you might have seen that Samsonite Group S.A. ( HKG:1910 ) released its quarterly result to the market. The...

Alibaba Health Information Technology (SEHK:241) has reported FY 2026 first half revenue of about CN¥16.7b and basic EPS of CN¥0.0786, set against trailing twelve month revenue of roughly CN¥34.3b and EPS of CN¥0.1202 as the latest datapoints in its growth story. Over recent periods, revenue has moved from around CN¥14.3b in FY 2025 first half to CN¥16.7b in FY 2026 first half, with basic EPS shifting from CN¥0.0479 to CN¥0.0786 as net profit margins improved from 4.7% to 5.7% and earnings...

Recent reports on underreported bad loans at major Chinese banks have put Bank of China (SEHK:3988) in focus, as investors weigh how prolonged regulatory forbearance might affect asset quality and disclosure. See our latest analysis for Bank of China. At a share price of HK$5.22, Bank of China has seen a 12.26% 90 day share price return and a 15.23% year to date share price return. The 5 year total shareholder return of 153.11% suggests longer term investors have experienced a very strong...

Hua Hong Semiconductor (SEHK:1347) opened Q1 2026 with revenue of about C¥4.6b and basic EPS of C¥0.08, against a backdrop of trailing twelve month EPS growth of 127.1% and revenue of roughly C¥17.3b. Over the last reported quarters, the company has seen quarterly revenue move from about US$3.9b in Q4 2024 to roughly US$4.6b in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.11 in Q4 2024 to US$0.07 in Q4 2025 as trailing net income reached about C¥495.3m. With net margin...